CTX-M-12 beta-lactamase in a Klebsiella pneumoniae clinical isolate in Colombia.

Antimicrob Agents Chemother

Línea de Resistencia Bacteriana, Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia.

Published: February 2004

We describe the detection of the CTX-M-12 beta-lactamase from a clinical isolate of Klebsiella pneumoniae in Colombia. Screening of nosocomial Klebsiella spp. and Escherichia coli isolates from a network of teaching hospitals revealed the presence of CTX-M enzymes in multiple cities. This is the first description of CTX-M in Colombia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC321560PMC
http://dx.doi.org/10.1128/AAC.48.2.629-631.2004DOI Listing

Publication Analysis

Top Keywords

ctx-m-12 beta-lactamase
8
klebsiella pneumoniae
8
clinical isolate
8
beta-lactamase klebsiella
4
pneumoniae clinical
4
isolate colombia
4
colombia describe
4
describe detection
4
detection ctx-m-12
4
beta-lactamase clinical
4

Similar Publications

The discharge of untreated or partially treated wastewater can have detrimental impacts on the quality of water bodies, posing a significant threat to public health and the environment. In Ecuador, previous research indicates a high prevalence of antimicrobial resistant (AMR) bacteria in surface waters affected by human activities, including irrigation channels. In this study, we analyzed sediment samples collected from an irrigation channel utilized for agricultural purposes in northern Ecuador, using microbiological techniques and whole-genome sequencing (WGS).

View Article and Find Full Text PDF

Background: Resistance to different antimicrobial classes by Salmonella species has generated a global public health concern. The spread of extended-spectrum β-lactamases (ESBLs) bla gene variants is also increasing. This study aimed to investigate the antibiotic resistance and the carriage of bla and bla as well as the quinolone resistance gene (qnrB19) among Salmonella species from hospitalised patients in Lagos, Nigeria.

View Article and Find Full Text PDF

Cefotaximase-Munich (CTX-M) extended-spectrum beta-lactamase (ESBL) enzymes produced by confer resistance to clinically relevant third-generation cephalosporins. CTX-M group 1 variants, CTX-M-1 and CTX-M-15, are the leading ESBL-producing associated with animal and human infection, respectively, and are an increasing antimicrobial resistance (AMR) global health concern. The and genes encoding these variants have an approximate nucleotide sequence similarity of 98.

View Article and Find Full Text PDF

Cefotaximase-Munich (CTX-M) extended-spectrum beta-lactamases (ESBLs) are commonly associated with Gram-negative, hospital-acquired infections worldwide. Several beta-lactamase inhibitors, such as clavulanate, are used to inhibit the activity of these enzymes. To understand the mechanism of CTX-M-15 activity, we have determined the crystal structures of CTX-M-15 in complex with two specific classes of beta-lactam compounds, desfuroylceftiofur (DFC) and ampicillin, and an inhibitor, clavulanic acid.

View Article and Find Full Text PDF

Colistin-resistant mcr-1-positive Escherichia coli ST1775-H137 co-harboring bla and bla recovered from an urban stream.

Infect Genet Evol

December 2021

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP) - Ribeirão Preto, Brazil. Electronic address:

The rapid dissemination of colistin resistance mcr-type genes and extended-spectrum β-lactamase-encoding genes at the human-animal-environment interface has raised concerns worldwide. In this study, we performed a genomic investigation of a multidrug (MDR)- and colistin-resistant Escherichia coli strain recovered from an urban stream strongly affected by pollution and used for recreational purposes in Brazil. E.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!